// App-Quantinova.ai

: Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy

Researchers

Presenter

  • Hana Mllerov

Principal Investigators

  • Celine El-Baou

  • Dmitry Galkin

  • Paul Jones

Medical Centers

  • Real World Evidence&Epidemiology, GSK R&D, Uxbridge, United Kingdom

  • RWD&Analytics, GSK R&D, Uxbridge, United Kingdom

  • Global Respiratory Franchise, Research Triangle Park, United States of America

  • Global Respiratory Franchise, GSK, Brentford, Middlesex, United Kingdom,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Eosinophil

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • NCT01516528

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved